NCT07086144 Efficacy of a Myocardial Panel in the Management and Treatment of Pediatric Myocarditis
| NCT ID | NCT07086144 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Azienda Ospedaliero, Universitaria Ospedali Riuniti |
| Condition | Myocarditis |
| Study Type | INTERVENTIONAL |
| Enrollment | 30 participants |
| Start Date | 2024-01-01 |
| Primary Completion | 2025-09-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 30 participants in total. It began in 2024-01-01 with a primary completion date of 2025-09-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this observational study is to determine the efficacy a of combined management and treatment driven by the systematic determination of viral genome, bacterial serology, and markers of inflammation in pediatric patients (\< 18 years old) diagnosed with myocarditis complicated by arrhythmias (supraventricular and ventricular tachycardias and heart block) or ventricular dysfunction (left ventricular ejection fraction \< 50% or right ventricular fractional area change \< 35%). The main question it aims to answer is: Does this panel help resolve arrhythmias or myocardial dysfunction due to myocarditis during hospitalisation and follow-up? Researchers will compare patients managed and treated in 2024 without applying the myocarditis panel with those enrolled in 2025 who received the panel. Arrhythmias and myocardial dysfunction will be managed in accordance with recent guidelines. Antiviral, antibiotic or immunosuppressive therapies will be implemented in addition to standard therapy when required by the panel.
Eligibility Criteria
Inclusion Criteria: * All the consecutive pediatric patients (\< 18 years old) presenting with myocarditis complicated by arrhythmias or myocardial dysfunction Exclusion Criteria: * Refused consent to be included in the study given by parents or legal tutors * Uncomplicated myocarditis presenting without arrhythmias or myocardial dysfunction
Contact & Investigator
Francesco Bianco, M.D., Ph.D., MSc, FEACVI
✉ francesco.bianco@ospedaliriuniti.marche.it📞 +39 071 596 5527
Frequently Asked Questions
Who can join the NCT07086144 clinical trial?
This trial is open to participants of all sexes, up to 18 Years, studying Myocarditis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07086144 currently recruiting?
Yes, NCT07086144 is actively recruiting participants. Contact the research team at francesco.bianco@ospedaliriuniti.marche.it for enrollment information.
Where is the NCT07086144 trial being conducted?
This trial is being conducted at Ancona, Italy.
Who is sponsoring the NCT07086144 clinical trial?
NCT07086144 is sponsored by Azienda Ospedaliero, Universitaria Ospedali Riuniti. The trial plans to enroll 30 participants.